HFB200603

Other Medications

EU Experimental ES Not available 1 Clinical Trials

Description

HFB200603 is an experimental medication currently being studied in clinical trials for various advanced cancers, including colorectal cancer. It is being investigated as a potential treatment option, sometimes in combination with other therapies like tislelizumab (an immunotherapy drug). The trials are in the early phase (Phase 1), meaning they are primarily focused on determining the safety and appropriate dosage of the drug. Some trials specifically include patients with colorectal cancer that has a BRAF V600E mutation. HFB200603 is not yet approved for use in colorectal cancer or any other cancer.

Mechanism of Action

HFB200603 is being studied as a potential cancer treatment. The specific way it works (its mechanism of action) is still under investigation in clinical trials. It is designed to target processes involved in cancer development or progression.

Side Effects

As HFB200603 is an experimental drug in early-phase clinical trials The full range of potential side effects is still being evaluated. Information about side effects from these early trials is limited. Researchers are carefully monitoring participants in the trials to assess safety and identify any adverse events.

Not all side effects are listed. Side effects vary by individual. Always consult your oncologist.

Clinical Trials

NCT05789069 Phase 1
Active, not recruiting
A Study of HFB200603 as a Single Agent and in Combination With Tislelizumab in Adult Patients With Advanced Solid Tumors
United States, Italy, Spain

Quick Info

CategoryOther Medications
EU EMA StatusExperimental
ES Spain AccessNot available
Clinical Trials1
View Clinical Trials Back to Drug Glossary

Related Medications

Uracil
Other Medications
771 trials
Leucovorin
Other Medications
631 trials
Trifluridine
Other Medications
45 trials
Paclitaxel
Other Medications
43 trials
Cyclophosphamid
Other Medications
40 trials
Cyclophosphamide
Other Medications
39 trials

Medical Disclaimer

This information is for educational purposes only and should not replace professional medical advice. Always consult your healthcare team before making treatment decisions.